Features of Prescribing Modern Sugar-Lowering Drugs to Patients with Type 2 Diabetes Mellitus


  • (1)  Badridinova B. K.            Bukhara State Medical Institute, Bukhara, Uzbekistan  
            Uzbekistan
    (*) Corresponding Author

Keywords:

diabetes mellitus, hyperglycemia, insulin resistance, secretagogues

Abstract

The number of patients with type 2 diabetes mellitus (DM2) is steadily increasing. According to Diabetes Atlas 2021, there are 536 million people with type 2 diabetes worldwide. At the same time, experts say that the number of undiagnosed diabetes mellitus (DM) may exceed the level recorded today by 2-3 times. Therefore, rational pharmacotherapy of this disease is the subject of numerous scientific and clinical studies. One of the largest recent studies has been the UK Diabetes Control and Complications Prospective Study (UKPDS). It lasted for about 20 years more than 5000 patients with type 2 diabetes participated in it. Patients were divided into groups who received different types of treatment since the moment of DM detection: only diet, various oral hypoglycemic drugs, insulin therapy.

Downloads

Download data is not yet available.

References

Aslonova Sh.Zh., Badridinova B.K. Influence of moxonidine on the main components of the metabolic syndrome // Biology and Integrative Medicine. 2017. №3. URL: https://cyberleninka.ru/article/n/vliyanie-moksonidina-na-osnovnye-komponenty-metabolicheskogo-sindroma (date of access: 06/03/2022).

American Diabetes Association. “Standards of medical care in diabetes 2018”. Diabetes care 41. Suppl 1: s1-s159. Http://care.diabetesjournals.org/content/41/Supplement_1/S1

American Diabetes Association. “Standards of medical care in diabetes—2018 abridged for primary care providers.” Clinical Diabetes 36.1 (2018): 14-37. Http://clinical.diabetesjournals.org/content/36/1/14

Khafiza I. ZHURAEVA,Barno K. BADRIDINOVA,Khilola Sh. YAKHOYEVA,Mehriban Akhmadovna RIZAEVA. (2021). Peculiarities of the course of joint syndrome in persons with type 2 diabetes mellitus. Journal of Natural Remedies, 22(1(1), 92-98. Retrieved from http://www.jnronline.com/ojs/index.php/about/article/view/770

Dedov I.I., Melnichenko G.A., M. Algorithms of specialized medical care for patients with diabetes mellitus, edition 4 supplemented, ed.: Informpolygraph LLC, 2019. - 104 p.

Dedov, I.I., M.V. Shestakova. Diabetes mellitus: a guide for doctors M., Universum Publishing, 2013. - 455 p.

IDF Diabetes Atlas 2021 – 10th edition.

Firuza Takhirova, Nodira Alikhanova; Diabetes mellitus in the Tashkent region of Uzbekistan/Endocrine Abstracts (2022) 81 EP1189.

Firuza Takhirova, Nodira Alikhanova, Vol. 2 No. 1 (2022): British Medical Journal.

Published

2022-06-13

How to Cite

K., B. B. . (2022). Features of Prescribing Modern Sugar-Lowering Drugs to Patients with Type 2 Diabetes Mellitus. Middle European Scientific Bulletin, 25, 132-139. Retrieved from https://cejsr.academicjournal.io/index.php/journal/article/view/1368

Issue

Vol. 25 (2022): June

Section

Education
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The work simultaneously licensed under a Creative Commons Attribution 4.0 International License

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.